Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-03

Clinical Trial Update: Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy

View source ↗

Summary

This document notes the completion of a clinical trial comparing Bromday (bromfenac) versus Nevanac (nepafenac) eye drops for pain control after photorefractive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromday (bromfenac)
  • Nevanac (nepafenac)

Snippet

Sponsor: Virdi Eye Clinic | Conditions: Myopia | Status: COMPLETED